Immunotherapy Improves the Survival of Stage 4 Non–Small Cell Lung Cancer Patients at the US Population Level: The Real‐World Evidence
ABSTRACT Introduction Immunotherapy has revolutionized the management of lung cancer and improved lung cancer survival in trials, but its real‐world impact at the population level remains unclear. Methods Using data obtained from eight Surveillance, Epidemiology, and End Results (SEER) registries fr...
Saved in:
| Main Authors: | Yuxuan Wei, Rui Zhang, Ruikang Yin, Shijie Wang, Jianglong Han, Ruyan Chen, Zhenming Fu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | The Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/crj.70000 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Immunotherapy in the Treatment of Hepatocellular Carcinoma
by: Irina Y. Dobrosotskaya, et al.
Published: (2025-04-01) -
Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
by: Lior Apter, et al.
Published: (2024-10-01) -
Joinpoint regression and age period cohort analysis of global and Chinese HIV incidence trends from 1990 to 2021
by: Menghan Wu, et al.
Published: (2025-03-01) -
Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations
by: Masato Kikuta, et al.
Published: (2025-01-01) -
Osteosarcoma: current insights and advances
by: Guraustin S. Brar, et al.
Published: (2025-06-01)